The effect of inhalant budesonide with surfactant prescription in the treatment of respiratory distress syndrome in premature infants
Not Applicable
- Conditions
- neonatal respiratory distress syndrome.Respiratory distress of newborn
- Registration Number
- IRCT2017053034219N1
- Lead Sponsor
- Research Department of Jondi Shapoor University of Medical Sciences, Ahvaz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
(All of the following) premature infants weighing less than 1500 grams; have respiratory distress syndrome; require a surfactant; treated with CPAP and with FIo2> 40%.
exclusion criteria:Infants weighing less than 1000 grams; more than 2 twin pregnancies; pregnancies with birth trauma; congenital anomalies; perinatal asphyxia; neonatal transfers from other institutions.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of respiratory support required. Timepoint: The first two weeks after the intervention. Method of measurement: Recording of the time between the onset and the end of respiratory support.;Duration of additional oxygen requirement. Timepoint: The first two weeks after the intervention. Method of measurement: Recording of the time between the onset and the end of oxygen therapy.
- Secondary Outcome Measures
Name Time Method ength of stay in hospital. Timepoint: one month. Method of measurement: The time between admission and the beginning of the intervention until the end of the intervention and discharge from the hospital.;The number of deaths. Timepoint: one month. Method of measurement: The number of cases of intervention or control that died during the study.